Category: Negative-Pressure Wound Therapy

SNN, KCI split German court ruling over NPWT patent

August 16, 2010 by MassDevice staff

A German court issues a split decision in a patent infringement lawsuit between Smith & Nephew plc and Kinetic Concepts Inc. over negative-pressure wound therapy.

A German court handed down a split decision in the long-running patent battle between Smith & Nephew plc (NYSE:SNN) and Kinetic Concepts Inc. (NYSE:KCI), over negative-pressure wound therapy, ruling that one version of Smith & Nephew's Renasys system infringes a KCI patent but clearing another model.

Smith & Nephew appeal in patent fight with KCI slated for October

August 3, 2010 by MassDevice staff

After recently picking up a British court victory, Kinetic Concepts Inc. (NYSE:KCI) and Smith & Nephew Group plc (NYSE:SNN) are heading back to court in October in their long-running fight over who can legally market negative-pressure wound therapies in the United Kingdom and beyond.

British court deals Smith & Nephew a setback in NPWT war with Kinetic Concepts

June 25, 2010 by MassDevice staff

A British court dealt Smith & Nephew plc (NYSE:SNN) a blow in its long-running patent infringement war with Kinetic Concepts Inc. (NYSE:KCI), ruling that two of Smith & Nephew's Renasys negative-pressure wound therapy devices infringe patents owned by KCI.

The ruling, by Judge Richard Arnold of the

KCI steps up as FDA's first guinea pig for home-use device labeling program

June 3, 2010 by MassDevice staff

Kinetic Concepts Inc. (NYSE:KCI) is the first manufacturer to take up a new Food & Drug Administration program for labeling home-use medical devices.

The San Antonio, Texas-based device maker will voluntarily submit labeling to the FDA as part of the agency's medical device Home Use Initiative, a 10-month pilot program for manufacturers to submit labeling of home-use medical devices to a central website.

Jury rules for KCI in NPWT spat with Smith & Nephew

March 10, 2010 by MassDevice staff

A Texas jury handed a win to Kinetic Concepts Inc. (NYSE:KCI) in its wound care war with Smith & Nephew (NYSE:SNN), ruling that the British medical products conglomerate infringed a pair of KCI-licensed patents with its Renasys-F negative-pressure wound therapy.

The jury in the U.S. District Court for Western Texas decided that the Smith & Nephew product violates a pair of patents owned by Wake Forest University and licensed to KCI, which sued Smith & Nephew for patent infringement in 2008. The jury found that KCI showed it lost about $900,000 in profits and about $143,000 in lost royalties due to the infringement, which also cost Wake Forest roughly $186,000 in lost royalties, according to court documents.

Wound care war between Kinetic Concepts and Smith & Nephew goes another round

November 18, 2009 by MassDevice staff

A federal judge in Texas shot down a salvo fired by Kinetic Concepts Inc. (KCI) in its wound care war with Smith & Nephew (SNN), denying KCI's motion to bar its British competitor from marketing negative pressure wound therapy kits using foam dressings.

KCI sued Smith & Nephew for patent infringement, alleging that its Renasys-F foam dressing kits violated a pair of KCI patents. The San Antonio, Texas-based wound care firm wanted Judge Royal Fergeson of the U.S. District Court for Western Texas to enjoin Smith & Nephew from selling any NPWT kits using the Renasys dressing.